Robert Peter Kadlec

Insider Reports History

Entity
Individual
Location
C/O Mink Therapeutics 149 Fifth Avenue, New York, NY
Signature
/s/Christine Klaskin, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Peter Kadlec:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MiNK Therapeutics, Inc. Director Common Stock 12.3K $8.97K $0.73 Dec 1, 2024 Direct
MiNK Therapeutics, Inc. Director Stock Option 41.7K Oct 30, 2024 Direct

Insider Reports Filed by Robert Peter Kadlec

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INKT MiNK Therapeutics, Inc. Oct 30, 2024 2 $8.97K 4 Dec 9, 2024 Director
INKT MiNK Therapeutics, Inc. Oct 30, 2024 0 $0 3 Dec 9, 2024 Director